SOURCE: Xtalks

Xtalks Webinars

November 12, 2014 07:05 ET

Xtalks Presents Live Webinar on Emerging Paradigms in Hematology/Oncology: Leveraging Quantitative and Qualitative Insights to Gain Competitive Advantage

TORONTO, ON--(Marketwired - November 12, 2014) - This webinar will provide insight on several paradigm shifts in the treatment of cancer and expose some unique quantitative and qualitative approaches to prospectively identify leading indicators suggestive of emerging treatment patterns. Join this interactive webinar to learn more on Wednesday, November 19, 2014 at 11am EST (4pm GMT).

The field of cancer treatment is highly complex, experiencing an evolution in methodologies and therapies to address the disease. Demands to show progress in reducing cancer-related deaths are at an all-time high, making it crucial for manufacturers to stay abreast of the issues and practices that ensure their products meet the needs of the market and experience positive results.

This webinar will provide insight on several paradigm shifts in the treatment of cancer and expose some unique quantitative and qualitative approaches to prospectively identify leading indicators suggestive of emerging treatment patterns. Through a case-study approach, data and insights in multiple tumor types will be presented to share real world situations and solutions.

The panel includes Doug Neely, Senior Director of Oncology Insights at Xcenda, and Arden Buettner, Director of Oncology Insights at Xcenda. Key takeaways of this session include:

  • Learn about recent paradigm shifts in the treatment of cancer
  • Explore new methods to approach and capture prospective market insights
  • Better understand the role of key drivers in physicians' decision making
  • Identify new ways to gain a competitive advantage via case study review

To learn more about this event visit: Emerging Paradigms in Hematology/Oncology: Leveraging Quantitative and Qualitative Insights to Gain Competitive Advantage

About Xcenda
Xcenda is a strategic consulting firm with 20 years of experience applying real-world expertise in health economics and outcomes research, reimbursement, health policy, market research, and market access strategy. As part of AmerisourceBergen Corporation, a leading global healthcare solutions company, Xcenda supports global pharmaceutical companies as well as emerging pre-commercialization phase firms with challenges such as developing an evidence package to optimize access in key global markets, predicting product performance, and identifying reimbursement strategies and programs to maximize patient access. From development through market maturity, Xcenda helps manufacturers identify, demonstrate, and deliver their brand's value proposition to key healthcare stakeholders. For more information visit http://www.xcenda.com/.

About Xtalks
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2014/11/11/11G026058/Images/Xcenda_CMYK_(1)-301466508781.JPG

Contact Information